| ARF1 |
|---|
| Protein Name | ADP Ribosylation Factor 1 |
| Gene | [ARF1](/genes/arf1) |
| UniProt ID | [P84077](https://www.uniprot.org/uniprot/P84077) |
| Protein Family | Arf family, GTP-binding proteins |
| Molecular Weight | 20.7 kDa |
| GTP/GDP Binding | GTP-bound = active, GDP-bound = inactive |
| Subcellular Localization | Golgi apparatus, plasma membrane, endosomes |
ARF1 (ADP Ribosylation Factor 1) is a small GTPase belonging to the ARF family of regulatory proteins. Originally identified as a cofactor for cholera toxin ADP-ribosylation, ARF1 is now recognized as a master regulator of membrane trafficking in eukaryotic cells. ARF1 controls vesicle formation, cargo transport, and organelle integrity through its GTPase cycle. Recent research has implicated ARF1 dysfunction in neurodegenerative diseases, particularly those involving protein aggregation like Alzheimer's disease and Parkinson's disease [1].
¶ Structure and GTPase Cycle
ARF1 is a 181-amino acid protein with the classic GTPase fold:
- N-terminal amphipathic helix: Myristoylated, anchors to membranes
- Switch I region: Conformational change between GTP/GDP states
- Switch II region: Critical for GTP hydrolysis
- GTP-binding domains: N, K, and D loops for nucleotide coordination
ARF1 cycles between active (GTP-bound) and inactive (GDP-bound) states:
- Activation: GEFs (Arfgef1/BIG1, Arfgef2/BIG2) catalyze GDP→GTP exchange
- Membrane recruitment: GTP-ARF1 exposes N-terminal helix, inserts into membrane
- Effector binding: Active ARF1 recruits coat proteins, adaptors, and enzymes
- Hydrolysis: GAPs (ArfGAP1, ArfGAP2/3) accelerate GTP hydrolysis
- Release: GDP-ARF1 dissociates from membrane for recycling
ARF1 is essential for Golgi apparatus function:
- COPI vesicle formation: Recruits coatomer complex to Golgi membranes
- Cargo sorting: Selects proteins and lipids for transport
- Golgi maintenance: Essential for Golgi stack organization
- ER-Golgi transport: Regulates anterograde and retrograde trafficking
ARF1 also regulates endosomal trafficking:
- Endosome function: Modulates endosomal maturation
- Lysosomal targeting: Directs cargo for degradation
- Recycling: Facilitates receptor recycling
ARF1 influences lipid homeostasis:
- Phospholipase D activation: PLD generates phosphatidic acid
- Phosphatidylinositol metabolism: Regulates PI4P levels at Golgi
- Membrane curvature: Facilitates vesicle budding
ARF1 dysfunction may contribute to Alzheimer's disease through several mechanisms:
The secretase enzymes that process amyloid precursor protein are localized to Golgi and endosomes:
- ARF1 regulates APP trafficking through the secretory pathway
- Altered ARF1 function may increase amyloidogenic processing
- Golgi fragmentation in AD neurons may involve ARF1 dysregulation
ARF1 interacts with tau phosphorylation pathways:
- GSK3β, a key tau kinase, may be regulated by ARF1
- Vesicular trafficking deficits affect tau spreading
In Parkinson's disease, ARF1 plays roles in:
- Alpha-synuclein trafficking: ARF1 regulates intracellular alpha-synuclein localization
- Autophagy: ARF1 modulates autophagosome formation
- Lysosomal function: Key for protein clearance pathways
- Mitochondrial dynamics: Links to PD-relevant pathways
ARF1 dysfunction may contribute to ALS pathogenesis:
- Vesicle transport deficits in motor neurons
- Protein aggregate clearance issues
- ER-Golgi stress responses
¶ ARF1 and Membrane Traffic in Neurodegeneration
Impaired vesicular trafficking contributes to protein aggregation:
- Secretory pathway stress: Accumulation of misfolded proteins
- Autophagy-lysosome pathway: Defects in aggregate clearance
- Axonal transport: Disrupted vesicle trafficking in neurons
Changes in membrane composition affect ARF1 function:
- Altered phosphoinositide metabolism
- Cholesterol accumulation
- Membrane fluidity changes
ARF1 and its regulators represent therapeutic targets:
- ARF GEFs: BIG1/BIG2 inhibitors for certain conditions
- ARF GAPs: Modulators of ARF activity
- Effector interactions: Disrupt toxic protein-protein interactions
For neurodegenerative applications:
- Small molecule modulators of ARF1 cycle
- Peptide inhibitors of specific interactions
- Gene therapy approaches
ARF1 is a small GTPase that regulates essential membrane trafficking pathways in all eukaryotic cells. In neurons, ARF1 controls vesicular transport critical for synaptic function, protein homeostasis, and organelle maintenance. Dysregulation of ARF1 function contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders through effects on protein processing, trafficking, and aggregation. Understanding ARF1 biology may reveal therapeutic strategies for these conditions.